Intervención farmacológica para disminuir la prevalencia de vulvovaginitis por cándida en gestantes. Arosemena Tola, Napo.

Abstract

The objective of this research was to reduce the prevalence of candida vulvovaginitis in pregnant women who come to the Arosemena Tola health center. To comply with this, a pharmacological intervention was applied in 49 pregnant women diagnosed with the disease. The Morisky-Green test was applied to determine pharmacological adherence in pregnant women. The Ranges with Wilcoxon signs and the McNemar test were used to determine changes in the frequency of knowledge levels and prevalence of VVC comparing pretest and posttest results. The research found an average age of 22.4 years with a predominance of pregnant women between 18 and 25 years (38.8%) and in the second trimester of pregnancy (38.8%). 71.4% had comorbidities associated with a predominance of anemia (30.6%), intestinal parasitism (22.4%) and overweight (12.2%). The low level of knowledge on disease prevention prevailed (59.2%) and 49.0% of pregnant women reported a history of candida vulvovaginitis during pregnancy. It was concluded that the pharmacological intervention applied caused significant changes in the increase in the level of knowledge about disease prevention (p = 0.001) and in the decrease in the prevalence of the disease (p = 0.001). It is recommended to structure a health education program related to reproductive health that not only includes pregnant women but also all women of reproductive age to reduce the incidence and prevalence of cervical-vaginal infections.